U.S. Metals and Mining Stock News

NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

Bio-Techne (TECH) Stock Looks Fully Priced On Cash Flow And Earnings

Bio-Techne's share price has risen over the past year, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the stock trading at a premium, which sits uneasily against a five year return where investors would have seen a sizeable decline. Over the past five years, Bio-Techne shareholders would have seen the stock fall around 39%, which puts the recent recovery into a longer term context of weak returns. Future growth in demand for...
NYSE:VMC
NYSE:VMCBasic Materials

Is Rising Efficiency And Free Cash Flow Altering The Investment Case For Vulcan Materials (VMC)?

Recently, Vulcan Materials reported that over the last five years it has grown annual revenue by 10.6%, gained market share this cycle, improved operating leverage on fixed costs, and expanded its free cash flow margin. This combination of higher efficiency, stronger profitability, and more free cash available for reinvestment or shareholder returns points to meaningfully stronger underlying business fundamentals. Next, we’ll assess how this improved operational efficiency and free cash flow...
NYSE:GIS
NYSE:GISFood

General Mills (GIS) Could Be 5% Undervalued On New Totino's Launches And Farm Tie Up

Why General Mills Stock Is Back on Investors’ Radar General Mills (GIS) has drawn fresh attention after announcing a new regenerative agriculture collaboration with ADM and Walmart, along with a broad expansion of Totino’s Pizza Rolls and Ultimate Pizza flavors across U.S. retailers. See our latest analysis for General Mills. For context, General Mills’ share price is US$36.03, with a 1-day share price return of 1.35% and a 90-day share price return of 3.77%. The 1-year total shareholder...
NasdaqGS:LPLA
NasdaqGS:LPLACapital Markets

Did HighWater Wealth’s Move to LPL (LPLA) Redefine Its High-Net-Worth Advisor Expansion Narrative?

LPL Financial LLC recently announced that HighWater Wealth, a multi-generational, planning-first advisory team serving about US$2.40 billion in advisory assets, has joined its broker-dealer and RIA platform via Quotient Advisor Partners after leaving U.S. Bank. This move underscores LPL’s appeal to high-net-worth focused advisors seeking independence, open-architecture platforms and advanced trust and estate planning resources to support customized, multi-generational wealth solutions. We’ll...
NYSE:MPC
NYSE:MPCOil and Gas

Marathon Petroleum (MPC) Stock Could Be 22% Below Fair Value Despite Earnings Focus

Marathon Petroleum stock has delivered a very large 5 year return, yet its valuation checks send mixed signals, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside while market based multiples lean expensive. Over the past 5 years, Marathon Petroleum has returned roughly 5.3x an initial investment, which puts extra focus on whether recent gains leave much room for further value. Upcoming earnings expectations for the largest refining system in the U.S. can support...
NYSE:ZGN
NYSE:ZGNLuxury

What Ermenegildo Zegna (ZGN)'s Stronger Q2 2026 Revenue Means For Shareholders

Ermenegildo Zegna N.V. has reported past unaudited revenues of €517,115,000 for the second quarter and €987,290,000 for the first half of 2026, both higher than the same periods a year earlier. The uplift in quarterly and half-year revenues suggests that Zegna’s mix of high-end collections and brand portfolio may be gaining commercial traction across key regions. We’ll now consider how this recent revenue growth, particularly the stronger second-quarter performance, could influence Zegna’s...
NYSE:AGL
NYSE:AGLHealthcare

Agilon Health (AGL) Stock Looks Discounted Even After A 482% Run

agilon health has delivered a very large year to date gain of 481.9%, yet its latest valuation checks still point to shares looking cheap on several measures. This sets up a clear tension between recent momentum and what the numbers currently suggest about pricing. The year to date return of 481.9% leaves existing shareholders with substantial gains, and raises the bar for new buyers who now need stronger fundamentals to justify the move. Expectations for agilon health's ability to grow its...
NYSE:ORI
NYSE:ORIInsurance

How Investors May Respond To Old Republic International (ORI) Strong Title Gains Amid Mixed Q2 2026 Results

Old Republic International Corporation recently reported past second-quarter 2026 results, with revenue rising to US$2,503.8 million and net income to US$322.3 million, alongside materially higher earnings per share versus a year earlier. Beneath the headline growth, strong gains in Title Insurance and higher investment income were partly offset by weaker Specialty Insurance results, reserve additions, and increased technology spending, while continued share repurchases under the August 2025...
NYSE:CRM
NYSE:CRMSoftware

Salesforce (CRM) Faces A New Slack Rival As Jack Dorsey Launches Buzz

Jack Dorsey has launched Buzz, a new open source group chat platform positioned as a direct competitor to Salesforce's Slack. Buzz aims to combine human conversations with AI agents in a single workflow-focused interface. This move introduces a fresh challenger in enterprise collaboration tools, with potential implications for Salesforce's AI driven productivity plans. For investors watching Salesforce (NYSE:CRM), the arrival of Buzz comes at a time when collaboration tools sit at the core...
NasdaqGM:HRMY
NasdaqGM:HRMYPharmaceuticals

Did CFO Exit and Reaffirmed 2026 Guidance Just Shift Harmony Biosciences' (HRMY) Investment Narrative?

Harmony Biosciences Holdings, Inc. recently announced that Chief Financial Officer Glenn Reicin stepped down on July 16, 2026, with Senior Vice President and Controller Stephen Mollichella appointed as Interim Principal Financial Officer while the company searches for a permanent successor. At the same time, Harmony reaffirmed its full-year 2026 net product revenue guidance of between US$1.00 billion and US$1.04 billion, signaling confidence in its operations despite the leadership...
NYSE:BVN
NYSE:BVNMetals and Mining

Buenaventura (BVN) Stock May Trade At A Discount Following Q2 Results

Compañía de Minas BuenaventuraA’s stock has had a very strong three year run, yet current valuation checks still indicate upside, with both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples pointing to the shares screening as undervalued. Over the past three years, the stock has returned 333.9%, which puts extra focus on whether today’s price still leaves room relative to its estimated intrinsic value. The latest production update and upcoming management discussion...
NYSE:MCY
NYSE:MCYInsurance

Is Mercury General (MCY) Fairly Valued After Fresh Analyst Praise?

Fresh analyst commentary highlighting Mercury General (MCY) as a value stock, with lower P/E and P/S ratios than peers and a positive earnings outlook, has drawn renewed attention from investors. See our latest analysis for Mercury General. Mercury General’s share price has moved steadily higher over the year, with a 16.9% year to date share price return and a 56.25% 1 year total shareholder return suggesting momentum has been building alongside the improving value story. If this kind of...
NasdaqCM:RGTI
NasdaqCM:RGTISemiconductor

Rigetti Computing (RGTI) Stock Trades At A Premium Despite A Very Large 3 Year Return

Rigetti Computing stock has delivered a very large 3 year gain, yet its recent share price pullback and weak overall value score suggest the current valuation may be demanding rather than an obvious bargain. Over 3 years, Rigetti Computing has returned a very large multiple on the share price, which makes the current level especially sensitive to how the business develops from here. Winning a contract to supply a 108 qubit quantum computer to India’s C DAC can support expectations for future...
NYSE:AIG
NYSE:AIGInsurance

How Investors Are Reacting To AIG’s Dividend Hike And 2026 Earnings Guidance Shift

In recent months, American International Group (AIG) lifted its annualized dividend by 14.3% year over year, taking its yield above the finance industry average and pairing this with guidance for stronger earnings in 2026. This combination of robust dividend growth and upbeat earnings expectations signals management’s confidence in AIG’s cash generation and balance-sheet flexibility. Against this backdrop of faster dividend growth, we’ll examine how the latest update could reshape AIG’s...
NYSE:TDC
NYSE:TDCSoftware

Teradata (TDC) Faces A Fresh AI Test Following Its Platform Launch

Teradata (TDC) has put its new Autonomous Knowledge Platform into full release, giving enterprises a single stack to run agentic AI across cloud, on premises, and hybrid setups with usage-aligned pricing. See our latest analysis for Teradata. Teradata's latest product announcements arrive during a mixed period for the stock, with a 1-day share price return of 3.03% to US$28.52, a 30-day share price return down 13.18%, and a 1-year total shareholder return of 29.28%. This points to positive...
NYSE:CVX
NYSE:CVXOil and Gas

Chevron (CVX) On Middle East Tensions, But Is The Valuation Case Still There?

Chevron (CVX) is back in focus as rising Middle East tensions and the closure of key shipping routes lift oil prices, while the company’s long dividend track record and favorable analyst coverage support investor interest. See our latest analysis for Chevron. Recent Middle East tensions and higher oil prices have coincided with a strong run in Chevron, with the stock at $194.79 and a 24.95% year to date share price return, alongside a 31.07% 1 year total shareholder return. This suggests that...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

Exelixis (EXEL) Stock Still Looks Like A Bargain On Earnings

Exelixis stock has quietly stacked up a strong share price record over the past five years, yet the current valuation checks still suggest the market may not be fully pricing in its fundamentals. Exelixis has returned 228.6% over five years, which puts a spotlight on whether the current share price fairly reflects that track record. Expectations around the durability of its revenue and cash flow from oncology treatments can support the current valuation, while any setback in clinical...
NYSE:FDX
NYSE:FDXLogistics

FedEx (FDX) Could Be 10% Undervalued After Shelf Filing And Strong Quarter

FedEx files new shelf registration after strong quarter FedEx (FDX) has filed an omnibus shelf registration for common stock and debt securities shortly after reporting better than expected fourth quarter results, putting fresh attention on the company’s future funding and capital plans. See our latest analysis for FedEx. FedEx’s recent shelf registration comes after a period where short term share price momentum has cooled, with the stock down 18.8% over 90 days. However, the 1 year total...
NYSE:BBWI
NYSE:BBWISpecialty Retail

How Investors May Respond To Bath & Body Works (BBWI) Localized Brazil Launch And Viva Collection

Bath & Body Works, Inc. has already entered Brazil with its first store and digital destination, tailoring assortments like fruity and tropical fragrances and the Brazil-inspired Viva collection to local consumer preferences. This move adds Brazil to a network of more than 550 international locations across over 45 countries, highlighting how its franchise-partner model is being used to refine assortments using regional consumer insight. Next, we’ll examine how this Brazil entry,...
NYSE:FR
NYSE:FRIndustrial REITs

First Industrial Realty Trust (FR) Stock Looks Near Fair Value While Earnings Trade At A Discount

First Industrial Realty Trust stock has delivered a 42.3% return over the past three years, and the latest checks point to a company that now looks closer to fairly priced. The Discounted Cash Flow (DCF) intrinsic value estimate is sitting near the current share price, while earnings based multiples still screen as supportive. Over the last 3 years, First Industrial Realty Trust has returned 42.3%, which puts more pressure on investors to judge whether the current level offers enough...
NasdaqGS:CSX
NasdaqGS:CSXTransportation

CSX (CSX) After Earnings And Guidance Update, Is The Valuation Story Too Full?

CSX (CSX) is back in focus after releasing second quarter 2026 results, updating its full year guidance and detailing recent buybacks and dividend plans, giving investors fresh information to assess the stock. See our latest analysis for CSX. CSX shares have been climbing, with a 30 day share price return of 11.69% and a year to date share price return of 46.76%. The 1 year total shareholder return of 50.96% points to strong momentum building around the stock. If the recent move in CSX has...
NYSE:AGCO
NYSE:AGCOMachinery

AGCO (AGCO) Stock May Be Below Fair Value On Precision Farming News

AGCO stock has gained 14.5% year to date, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a discount to what the underlying business may justify. Year to date, AGCO is up 14.5%, which puts recent returns into positive territory while still leaving room for a potential valuation gap. Attention on agricultural machinery components and precision farming, including AGCO's involvement in brand agnostic precision...
NYSE:IRM
NYSE:IRMSpecialized REITs

Iron Mountain (IRM) Has Strong Long Term Momentum, Is A 26% Discount Still Real?

Iron Mountain stock in focus after recent performance shift Iron Mountain (IRM) is drawing attention after a mixed stretch in its share performance, with the stock up over the past 3 months but down over the past month, prompting fresh questions about valuation. See our latest analysis for Iron Mountain. At the latest share price of $128.31, Iron Mountain has seen strong momentum over the year, with a year to date share price return of 54.14% and a 1 year total shareholder return of 33.56%...
NasdaqGS:KMTS
NasdaqGS:KMTSMedical Equipment

Kestra Medical Technologies (KMTS) Secures $200 Million Debt Facility Without New Equity

Kestra Medical Technologies (NasdaqGS:KMTS) arranged a $200 million non-dilutive five year term loan facility. The financing includes new lending partnerships with BPCR Limited Partnership and BioPharma Credit Investments V. The company refinanced and retired existing debt as part of the transaction, while maintaining a solid cash position. Kestra Medical Technologies enters this financing with a mixed recent share price record. The stock is up 27.3% over the past year, while down 13.8%...